Beyond Phenylbutyric Acid: Evans Blue and Ibuprofen as Albumin- Binding Motifs for PSMA-Targeted Radioligand Therapy of Prostate Cancer

作者
Cyril Fersing,Johanne Vanney,Jade Torchio,Stéphane C. Renaud,Léa Rubira
出处
期刊:Current Topics in Medicinal Chemistry [Bentham Science Publishers]
卷期号:26 被引量:1
标识
DOI:10.2174/0115680266495475260908114649
摘要

INTRODUCTION: Radioligand Therapy (RLT) targeting Prostate-Specific Membrane Antigen (PSMA) reshapes the therapeutic landscape of metastatic castration-resistant prostate cancer. However, the rapid systemic clearance of small-molecule radioligands directly affects circulation time and tumor exposure. Reversible albumin binding emerged as a practical strategy to extend circulation and modulate biodistribution. Among drug-derived Albumin-Binding Moieties (ABMs), Evans Blue (EB) and ibuprofen (Ibu) offer distinct approaches to improve pharmacokinetics and the therapeutic index. METHODS: This review analyzes the design, synthesis, structure-activity relationships, and evaluation of PSMA radioligands incorporating EB- or Ibu-derived ABMs. Preclinical and clinical literature was examined, with emphasis on translational candidates. RESULTS: EB confers strong albumin binding and markedly prolongs tumor residence, whereas Ibu enables more finely tunable interactions with albumin. The impact of linker, radionuclide, and albumin affinity on biodistribution, dosimetry, and therapeutic efficacy are essential to consider. Available data suggest that albumin binding is a tunable pharmacokinetic parameter rather than a binary property. Clinical experience with EB-PSMA-617 and SibuDAB demonstrates that increasing tumor absorbed dose through prolonged circulation is achievable but may increase irradiation of kidneys, bone marrow, and salivary glands. DISCUSSION: These findings support the hypothesis that moderately strong, tunable albumin binding offers the most favorable therapeutic window. Stereochemical optimization of Ibu-derived ABMs and linker engineering illustrate how subtle structural changes can rebalance tumor uptake, clearance, and safety. Future radiopharmaceutical design will likely rely on iterative structure- pharmacokinetic optimization and dosimetry to define optimal albumin affinity. CONCLUSION: Overall, ABMs appear to be central tools for the design of next-generation PSMA radioligands and other radiopharmaceuticals.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
cmy完成签到,获得积分10
刚刚
1秒前
xinxin完成签到,获得积分10
1秒前
星辰大海的应助被Allen0520采纳,获得30
1秒前
哈哈怪完成签到 ,获得积分10
2秒前
英俊的铭的应助被清脆香露采纳,获得10
3秒前
Yuan88发布了新的文献求助10
3秒前
cmy发布了新的文献求助10
3秒前
3秒前
terryok发布了新的文献求助30
3秒前
4秒前
4秒前
4秒前
4秒前
Chloe完成签到,获得积分10
4秒前
5秒前
6秒前
Yuan88发布了新的文献求助10
6秒前
FashionBoy的应助被cuipi采纳,获得10
6秒前
今后的应助被忧郁的人英采纳,获得10
7秒前
7秒前
7秒前
7秒前
wanci的应助被知性的派大星采纳,获得10
8秒前
Fiszh发布了新的文献求助10
9秒前
星辰大海的应助被星辞采纳,获得10
9秒前
Yuan88发布了新的文献求助10
9秒前
10秒前
10秒前
11秒前
Mmmin完成签到,获得积分10
11秒前
丘比特的应助被flash采纳,获得10
12秒前
Yuan88发布了新的文献求助10
12秒前
12秒前
15秒前
半岛完成签到 ,获得积分10
15秒前
迷人雪一完成签到,获得积分10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184220
求助须知:如何正确求助?哪些是违规求助? 9573266
关于积分的说明 21830447
捐赠科研通 7781246
什么是DOI,文献DOI怎么找? 3434248
关于科研通互助平台的介绍 2558373
邀请新用户注册赠送积分活动 2480784